Increased MPT is associated with genetic loss of the tumor suppressors RB1 and TP53 and drives the aggressive phenotype of triple-negative breast cancers promoting mitochondrial OXPHOS, mesenchymal, and stem-like features [47]. This evidence concerns the gene TP53 and triple-negative breast carcinoma.